28-Aug-2019: The global point of care
testing market size is expected to reach USD 22.8 billion
by 2025, at a CAGR of 3.3%, according to a new report by Grand View Research,
Inc. The ability of Point of Care (POC) tests to render rapid and accurate
results to promote patient-centered healthcare at bedside settings as well as
in the remote areas results in higher penetration of POC devices and solutions.
Adaptation of
automated laboratory systems and highly integrated solutions facilitate the
diagnostic workflow, which in turn drives adoption of point of care
diagnostic/testing products. Lack of skilled professionals or medical personnel
with limited training especially in diagnostics can also easily use these
devices.
Rise in R&D
activities among key players to introduce novel POC tests and devices for rapid
disease detection and monitoring is expected to fuel industrial progression.
Recently, in February 2018, Siemens Healthineers received a Food and Drug
Administration (FDA) approval for its Total Carbon Dioxide (TCO2) and Blood
Urea Nitrogen (BUN) POC tests, thereby enhancing its market presence.
Moreover, high
prevalence of chronic disorders and cancer results in large customer base
adopting cost-effective and immediate diagnostic tests, propelling the point of
care diagnostics/testing market. This is further supplemented by numerous
favorable initiatives to promote the employment of POC tests in diagnosis and
screening procedures.
In the depth research report on Point of Care Diagnostics/Testing Market
Further key findings from the report suggest:
·
Glucose testing held the maximum revenue share in 2018 due to
high prevalence of diabetes and introduction of a wide variety of glucose
meters by companies
·
Hb1Ac testing segment is also expected to show similar trends
owing to high competition among key players while delivering low-cost Hb1Ac
tests
·
Detection and analysis of circulating tumor cells during
cancer progression is predicted to drive the cancer marker vertical with the
fastest penetration rate in the forthcoming years
·
Clinics is estimated to hold the dominant revenue share of
the POC diagnostic industry in 2018, due to the employment of a wide range of
POC tests
·
Increasing awareness about decentralized tests among patients
has resulted in lucrative growth of home-based POC testing
·
U.S. is anticipated to North America owing to the presence of
key participants with undergoing significant number of research endeavors in
the country
·
Continuous developments in healthcare sector to introduce
novel and accurate diagnostic tests exhibit a potential growth of the market in
Asia Pacific
·
Major participants in the point of care diagnostics market
include F. Hoffmann-La Roche Ltd.; Danaher Corporation; Abbott Laboratories;
bioMérieux SA; Instrumentation Laboratory SpA; Nova Biomedical; Trividia
Health, Inc.; QIAGEN; Becton Dickinson & Company; Sekisui Diagnostics LLC;
Quidel Corporation; and Siemens Healthcare GmbH
·
Key vendors are undergoing numerous strategic developments
such as product development, acquisitions, partnerships, and agreements to gain
greater market share. For instance, in May 2017, Becton, Dickinson and Company
collaborated with the FIND to develop point of care based biomarker test for
bacterial infections.
Grand View Research
has segmented the global point of care testing market on the basis of product,
end use, and region:
Point of Care Diagnostics/Testing Product Outlook (Revenue,
USD Million, 2014 - 2025)
·
Glucose Testing
·
Hb1Ac Testing
·
Coagulation
·
Fertility
·
Infectious Diseases
·
HIV POC
·
Clostridium Difficile POC
·
HBV POC
·
Pneumonia or Streptococcus Associated Infections
·
Respiratory Syncytial Virus (RSV) POC
·
HPV POC
·
Influenza/Flu POC
·
HCV POC
·
MRSA POC
·
TB and Drug-Resistant TB POC
·
HSV POC
·
Other Infectious Diseases
·
Cardiac Markers
·
Thyroid Stimulating Hormone
·
Hematology
·
Primary Care Systems
·
Decentralized Clinical Chemistry
·
Feces
·
Lipid Testing
·
Cancer Marker
·
Blood Gas/Electrolytes
·
Ambulatory Chemistry
·
Drug Abuse Testing
·
Urinalysis
Point of Care Diagnostics/Testing End Use Outlook (Revenue,
USD Million, 2014 - 2025)
·
Clinics
·
Physician Office
·
Pharmacy & Retail Clinics
·
Non-practice Clinics
·
Urgent Care Clinic
·
Hospitals
·
Home
·
Assisted Living Healthcare Facilities
·
Laboratory
Browse
more research reports of this category:
About
Grand View Research
Grand View Research, Inc. is the
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
No comments:
Post a Comment